NEW YORK – Swedish molecular diagnostics firm Devyser Diagnostics said on Tuesday that it has completed a SEK 130 million ($15.4 million) private placement of 7,465 shares with Swedbank Robur and Fourth Swedish National Pension Fund (AP4).
Devyser will use the proceeds to finance its global marketing and sales expansion.